<DOC>
	<DOCNO>NCT00253747</DOCNO>
	<brief_summary>The objective study evaluate whether Osmotic-Release Methylphenidate ( OROS MPH ) , relative placebo , increase effectiveness standard smoking treatment ( i.e. , nicotine patch individual smoking cessation counsel ) obtain prolonged abstinence smoker Attention Deficit Hyperactivity Disorder ( ADHD ) .</brief_summary>
	<brief_title>Smoking Cessation Adults With Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description>The primary objective study evaluate whether OROS MPH ( Concerta ) , relative placebo , increase effectiveness standard smoking treatment ( i.e. , nicotine patch individual smoking cessation counsel ) obtain prolonged abstinence smoker ADHD . The study involve estimate 252 participant , recruit approximately 6 site .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Clinical diagnosis ADHD2 Smoked cigarettes least 3 month Currently smoke &gt; 10 cigarettes/day Have interest quit Negative urine screen cocaine , methamphetamine , opiates , benzodiazepine , marijuana Have clinical diagnosis current abuse dependence psychoactive substance nicotine , depression , anxiety ; lifetime clinical diagnosis psychosis bipolar disorder Allergic OROSMPH Pregnant breastfeed Abnormal electrocardiogram ( ECG ) Taking Monoamine Oxidase ( MAO ) Inhibitor Taking medication use treat either ADHD smoking Use tobacco product cigarette past week Blood pressure reading great 135/85 and/or heart rate 90 beat per minute three consecutive clinic visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>